Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-11-15
2005-11-15
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S053000
Reexamination Certificate
active
06964949
ABSTRACT:
The present invention relates to a pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina which comprises sucrose and/to maltose, to the use of certain sucrose and/or maltose, in preparing the pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, in particular to a method of stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, treating the reduction of gram-positive bacilli and the lowness of acidity in vagina as well as the vaginitis and the disturbance of vaginal bacterioflora accompanying the reduction of gram-positive bacilli, especially bacterial vaginal disease.
REFERENCES:
patent: 3860707 (1975-01-01), Wootton
patent: 5518733 (1996-05-01), Lamothe et al.
patent: 6165997 (2000-12-01), Cohen et al.
patent: 6416779 (2002-07-01), D'Augustine et al.
patent: 6632796 (2003-10-01), Zeng
patent: 1104502 (1995-05-01), None
patent: 1104502 (1995-07-01), None
patent: 0 257 007 (1988-02-01), None
patent: 0 242 459 (1991-08-01), None
patent: 2 112 285 (1983-07-01), None
patent: WO-89/05645 (1989-06-01), None
patent: WO-93/14773 (1993-08-01), None
patent: WO 94/02148 (1994-02-01), None
patent: WO 94/03502 (1994-02-01), None
McDonald, H.M., et al.; “Vaginal Infection and Preterm Labour”;Br. J. Obstet Gynaecol; vol. 98, No. 5; pp. 427-435 (May 1991).
Thomason, Jessica L.; “Bacterial Vaginosis: Current Review With Indications for Asymptomatic Therapy”;Am.J. Obstet Gynecol; vol. 165; No. 4, Part 2; pp. 1210-1217 (1991).
Hillier, Sharon, L.; “Efficacy of Intravaginal 0.75% Metronidazole Gel for the Treatment of Bacterial Vaginoisis”;Obstet-Gynecol.; vol. 81, No. 6; pp. 963-967 (Jun. 1993).
Hallén, Anders, Md., et al.; “Treatment of Bacterial Vaginois With Lactobacilli”;Sex-Transm-Dis.; vol. 19, No. 3; pp. 146-148 (May-Jun. 1992).
Hughes, Viki, L.; “Microbiologic Characteristics of Lactobacillus Products Used for Colonization of the Vagina”;Obstetrics&Gynecology; vol. 75, No. 2; pp. 244-248 (Feb. 1990).
Eschenbach, David, A.; “Bacterial Vaginosis and Anaerobes in Obstetric-Gynecologic Infection”,Clinical Infectious Diseases; vol. 16; Supp. 4; pp. S282-S287 (1993).
Germain, Marc, et al., “Genital Flora in Pregnancy and Its Association With Intrauterine Growth Retardation”;J. Clin. Microbiol; vol. 32, No. 9; pp. 2162-2168 (Sep. 1994).
M.R. Guiraud, “Le Traitement Des Vulvo-Vaginites”, Bourdeaux Medical, France, vol. 11, No. 16, Jun. 1978, pp. 1393-1400.
B. Kaplan, et al., “Single-dose systemic oral fluconazole for the treatment of vaginal cadidiasis”, International Journal of Gynecology & Obstetrics, vol. 57, No. 3, 1997, pp. 281-286.
Peselev Elli
Shanghai Jiao Da Onlly Co., Ltd.
LandOfFree
Pharmaceutical compositions for promoting the growth of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for promoting the growth of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for promoting the growth of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3469886